Jennifer E. Thorne

17.1k total citations · 1 hit paper
228 papers, 8.4k citations indexed

About

Jennifer E. Thorne is a scholar working on Ophthalmology, Rheumatology and Epidemiology. According to data from OpenAlex, Jennifer E. Thorne has authored 228 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Ophthalmology, 45 papers in Rheumatology and 40 papers in Epidemiology. Recurrent topics in Jennifer E. Thorne's work include Ocular Diseases and Behçet’s Syndrome (167 papers), Retinal and Optic Conditions (103 papers) and Retinal Diseases and Treatments (61 papers). Jennifer E. Thorne is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (167 papers), Retinal and Optic Conditions (103 papers) and Retinal Diseases and Treatments (61 papers). Jennifer E. Thorne collaborates with scholars based in United States, United Kingdom and Australia. Jennifer E. Thorne's co-authors include Douglas A. Jabs, James P. Dunn, John H. Kempen, Eric B. Suhler, Sanjay Kedhar, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, C. Stephen Foster and Stephen J. Kim and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jennifer E. Thorne

212 papers receiving 8.2k citations

Hit Papers

Adalimumab in Patients with Active Noninfectious Uveitis 2016 2026 2019 2022 2016 100 200 300 400

Peers

Jennifer E. Thorne
John H. Kempen United States
David E. Yocum United States
Eun Bong Lee South Korea
Yeong Wook Song South Korea
Amr H. Sawalha United States
Elizabeth A. Sugar United States
Cheryl Enger United States
Charles B. Pratt United States
Arthur Weinstein United States
John H. Kempen United States
Jennifer E. Thorne
Citations per year, relative to Jennifer E. Thorne Jennifer E. Thorne (= 1×) peers John H. Kempen

Countries citing papers authored by Jennifer E. Thorne

Since Specialization
Citations

This map shows the geographic impact of Jennifer E. Thorne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Thorne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Thorne more than expected).

Fields of papers citing papers by Jennifer E. Thorne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Thorne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Thorne. The network helps show where Jennifer E. Thorne may publish in the future.

Co-authorship network of co-authors of Jennifer E. Thorne

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Thorne. A scholar is included among the top collaborators of Jennifer E. Thorne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Thorne. Jennifer E. Thorne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enjalbert, A, et al.. (2025). Peripapillary atrophy in patients with birdshot chorioretinitis. British Journal of Ophthalmology. 109(8). 882–887.
3.
Jabs, Douglas A., Elizabeth A. Sugar, Alyce Burke, et al.. (2025). Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. Ophthalmology. 133(3). 310–325.
4.
Tsui, Edmund, Jennifer E. Thorne, Alejandra de‐la‐Torre, et al.. (2025). Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis—Multimodal Imaging in Uveitis (MUV) Taskforce Report 5. American Journal of Ophthalmology. 276. 272–285. 3 indexed citations
5.
Hampanda, Karen, José Castillo‐Mancilla, Peter L. Anderson, et al.. (2024). Antiretroviral therapy adherence among peripartum women with HIV in Kenya: an explanatory mixed methods study using dry blood spot measures and narrative interviews. AIDS Care. 36(12). 1826–1837.
6.
Smith, Justine R., Jennifer E. Thorne, Christina J. Flaxel, et al.. (2024). Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies. Ophthalmology. 131(9). 1107–1120. 8 indexed citations
7.
Lang, Raynell, Sally B. Coburn, M. John Gill, et al.. (2024). The Association of Anemia With Survival Among People With HIV Following Antiretroviral Initiation in the NA-ACCORD 2007–2016. JAIDS Journal of Acquired Immune Deficiency Syndromes. 97(4). 334–343. 2 indexed citations
8.
Sugar, Elizabeth A., Alyce Burke, Vidya Venugopal, Jennifer E. Thorne, & Janet T. Holbrook. (2020). Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis. Ophthalmology. 127(12). 1710–1718. 7 indexed citations
9.
Jabs, Douglas A., et al.. (2019). Birdshot Chorioretinitis: Treatment & Remission Outcomes. Investigative Ophthalmology & Visual Science. 60(9). 3506–3506. 1 indexed citations
10.
Kempen, John H., Craig Newcomb, C. Stephen Foster, et al.. (2019). Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.. Investigative Ophthalmology & Visual Science. 60(9). 3854–3854. 1 indexed citations
11.
Thorne, Jennifer E., et al.. (2019). Ocular complications of checkpoint inhibitors and immunotherapy medications: a case series. Investigative Ophthalmology & Visual Science. 60(9). 3535–3535.
12.
Gueudry, J., et al.. (2016). Biologic Therapy for HLA-B27-associated Ocular Disorders. Ocular Immunology and Inflammation. 25(2). 169–178. 9 indexed citations
13.
Jaffe, Glenn J., Andrew D. Dick, Antoine P. Brézin, et al.. (2016). Adalimumab in Patients with Active Noninfectious Uveitis. New England Journal of Medicine. 375(10). 932–943. 418 indexed citations breakdown →
14.
Jaffe, Glenn J., Jennifer E. Thorne, David K. Scales, et al.. (2015). Adalimumab in Patients With Active, Non-infectious Uveitis Requiring High-dose Corticosteroids: the VISUAL-1 Trial. Investigative Ophthalmology & Visual Science. 56(7). 3115–3115. 4 indexed citations
15.
Thorne, Jennifer E., Namita Tundia, Martha Skup, et al.. (2014). Direct and Indirect Resource Use and Costs Associated With Non-Infectious Non-Anterior Uveitis. Investigative Ophthalmology & Visual Science. 55(13). 5320–5320. 1 indexed citations
16.
Kothari, Srishti, Maxwell Pistilli, C. Stephen Foster, et al.. (2014). Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis. Investigative Ophthalmology & Visual Science. 55(13). 844–844.
17.
Daniel, Ebenezer, Maxwell Pistilli, H. Nida Sen, et al.. (2014). Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis. Investigative Ophthalmology & Visual Science. 55(13). 6031–6031. 1 indexed citations
18.
Tundia, Namita, Martha Skup, Rachael Sorg, et al.. (2014). Risk of Leaving the Workforce in Non-infectious Uveitis. Investigative Ophthalmology & Visual Science. 55(13). 5309–5309. 1 indexed citations
19.
Kempen, John H., Mark L. Van Natta, Michael M. Altaweel, et al.. (2014). Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Investigative Ophthalmology & Visual Science. 55(13). 6036–6036. 1 indexed citations
20.
Iles, David, H. Rao Gattamaneni, Jennifer E. Thorne, et al.. (2002). Endocrinology and diabetes. Archives of Disease in Childhood. 86(Supplement 1). 8–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026